Aptevo Therapeutics Inc. (APVO) Gross margin 2016–2019
Aptevo Therapeutics Inc. (APVO) gross margin by fiscal year — reported gross profit divided by reported revenue.
13.6%FY2019 · since FY2016: 62.9% → 13.6%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2019 | 13.6% | -9.9 pp |
| FY2018 | 23.5% | -26.3 pp |
| FY2017 | 49.8% | -13.1 pp |
| FY2016 | 62.9% | — |
Gross margin = reported gross profit ÷ reported revenue for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice